← All stocks

GeneDx Holdings Corp.

WGS Scheduled selling only

CIK 0001818331 #1896 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$450.34K

$0.00 on a plan · $450.34K straight out of an exercise

Sold at will

$0.00

0 of 3 sales

Net

−$450.34K

$0.00 against sales at will

By person

11 insiders · 3 transactions

12.6×

Katherine Stueland holds 12.6 times base salary in stock. $9.03M of shares against $715.87K in salary for 2025.

Salary from the company's own proxy. The shares are what Katherine Stueland last reported holding, valued at $84.22, the price Class A Common Stock was last bought or sold at on the open market here, on 9 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Stueland Katherine

CHIEF EXECUTIVE OFFICER

—

$310.93K (1) scheduled

−$310.93K

107,227

0.3596%

$9.03M

+3.4%

Feeley Kevin

CHIEF FINANCIAL OFFICER

—

$139.41K (2) scheduled

−$139.41K

41,476

0.1391%

$3.49M

−53.7%

Meister Keith A.

Director

—

4,808,275

16.12%

$404.94M

+93.8%

Casdin Capital, LLC entity

Director

—

3,707,164

12.43%

$312.21M

+5.7%

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

10% owner

—

2,719,692

9.12%

$229.05M

−27.1%

RUCH JOSHUA

Director

—

153,382

0.5143%

$12.92M

−7.6%

Ryan Jason

Director

—

118,764

0.3982%

$10.00M

−64.0%

PFENNIGER RICHARD C JR

Director

—

45,082

0.1512%

$3.80M

+63.0%

Leproust Emily M.

Director

—

24,852

0.0833%

$2.09M

+197.6%

Casdin Eli

Director

—

24,093

0.0808%

$2.03M

+217.3%

Dechairo Bryan

Chief Operating Officer

—

0.0000%

$0.00

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 3

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 3

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 9,726

History held since 26 Jul 2021